FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 357:1796-1797 November 1, 2007 Number 18 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

On September 6, 2007, Senators Charles Grassley (R-IA), the ranking member of the Committee on Finance, and Herb Kohl (D-WI), chairman of the Special Committee on Aging, introduced the Physician Payments Sunshine Act — so named because it aims to "shine a much needed ray of sunlight on a situation that contributes to the exorbitant cost of health care," according to cosponsor Senator Charles Schumer (D-NY). The bill would require manufacturers of pharmaceuticals and medical devices with annual revenues of more than $100 million to disclose the amount of money they give to physicians — whether in the form of . . . [Full Text of this Article]

Source Information

Dr. Campbell is an associate professor at the Institute for Health Policy at Massachusetts General Hospital and Harvard Medical School, Boston.

This article has been cited by other articles:

• Liesegang, T. J. (2008). Commercialism, Loss of Professionalism, and the Effect on Journals. Arch Ophthalmol 126: 1292-1295 [Full Text]  
• Norris, J. W. (2008). The Ideal Antiplatelet Drug for Stroke Prevention--Still Elusive. Stroke 39: 1076-1077 [Full Text]  
• Stossel, T. P (2008). Has the hunt for conflicts of interest gone too far? Yes. BMJ 336: 476-476 [Full Text]